← Back to Clinical Trials
Recruiting NCT07250126

3D Biomimetic Spine Unit Model Through the Integration of Bioprinting and Transcriptomics (CDP-SUBT)

Trial Parameters

Condition Degenrative Disc Disease
Sponsor I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Study Type OBSERVATIONAL
Phase N/A
Enrollment 5
Sex ALL
Min Age 30 Years
Max Age 70 Years
Start Date 2025-11-04
Completion 2027-10

Brief Summary

The general objective of this project is to define the transcriptional profile of primary human cells derived from the nucleus pulposus (NP), annulus fibrosus (AF), and cartilaginous endplate (CEP), and to use this information as a reference to assess the biological relevance of a biomimetic spinal unit model obtained through bioprinting. By developing an in vitro model of human origin that incorporates key components of the spinal unit and applying transcriptional analyses to both native cells and their counterparts recovered from the 3D construct, the study will evaluate how accurately the bioprinted model reproduces the identity and heterogeneity of the native discal environment.

Eligibility Criteria

Inclusion Criteria: * Signature of the Informed Consent for the study * Age 30-70 years (included) * Pfirrmann grade III-V * Need to undergo spinal surgery Exclusion Criteria: * Presence of HIV, HBC, HCV or TPHA infection

Related Trials